Hi all, after scrolling through some posts on here, I got inspired to do a similar thing and created a Substack post doing due diligence on Inventiva SA (IVA) and their upcoming Phase 3 trial readout later this year. I've been following biotech stocks for a while now, but only recently started to share my insights like this, so if you're interested in reading some of my analysis, you can do so via this link and feel free to subscribe (also free):
[https://open.substack.com/pub/circeanalysis/p/due-diligence-inventiva-sa-iva?utm\_campaign=post-expanded-share&utm\_medium=web](https://open.substack.com/pub/circeanalysis/p/due-diligence-inventiva-sa-iva?utm_campaign=post-expanded-share&utm_medium=web)
I might also work on other projects on Substack, like showing my portfolio performance and current holdings.